Get the Stockscreener App
0.605
3.54%
0.0207
After Hours:
.59
-0.015
-2.48%
BiomX Inc stock is traded at $0.605, with a volume of 348.16K.
It is up +3.54% in the last 24 hours and up +27.45% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.5843
Open:
$0.647
24h Volume:
348.16K
Relative Volume:
0.08
Market Cap:
$16.07M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.9308
EPS:
-0.65
Net Cash Flow:
$-22.29M
1W Performance:
+10.20%
1M Performance:
+27.45%
6M Performance:
+12.45%
1Y Performance:
-37.51%
1-Day Range:
$0.5801
$0.647
1-Week Range:
$0.541
$0.647
52-Week Range:
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.605 | 15.52M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Analyzing BiomX Inc. with multi timeframe chartsRisk Management & Long-Term Safe Investment Ideas - newser.com
Predicting BiomX Inc. trend using moving averagesTreasury Yields & AI Powered Trade Plan Recommendations - newser.com
Will BiomX Inc. stock benefit from commodity pricesQuarterly Portfolio Review & High Return Trade Guides - newser.com
Full technical analysis of BiomX Inc. stockWeekly Gains Report & Weekly Return Optimization Alerts - newser.com
How BiomX Inc. stock reacts to inflationary pressures2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Is BiomX Inc. stock bottoming after sell offMarket Growth Report & Fast Momentum Stock Entry Tips - newser.com
Will BiomX Inc. see short term momentumWeekly Trend Summary & Daily Price Action Insights - newser.com
Measuring BiomX Inc.’s beta against major indices2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com
Why BiomX Inc. stock remains stableSell Signal & High Win Rate Trade Tips - newser.com
How BiomX Inc. stock trades in high volatility2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Why BiomX Inc. stock is popular among millennialsLayoff News & Real-Time Volume Analysis Alerts - newser.com
Is this a good reentry point in BiomX Inc.July 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
BiomX Inc. stock trend outlook and recovery path2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
How BiomX Inc. stock compares to market leadersQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
Sector ETF performance correlation with BiomX Inc.2025 Momentum Check & Real-Time Market Trend Scan - newser.com
What drives BiomX Inc stock priceEconomic Indicators Overview & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Why retail traders accumulate BiomX Inc. stockJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):